HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prolonged survival of a bare lymphocyte syndrome type I patient with diffuse panbronchiolitis treated with erythromycin.

AuthorsA Azuma, N Keicho, H Furukawa, T Yabe, S Kudoh
JournalSarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG (Sarcoidosis Vasc Diffuse Lung Dis) Vol. 18 Issue 3 Pg. 312-3 (Oct 2001) ISSN: 1124-0490 [Print] Italy
PMID11587107 (Publication Type: Case Reports, Letter)
Chemical References
  • Anti-Bacterial Agents
  • Histocompatibility Antigens Class I
  • Erythromycin
Topics
  • Adult
  • Anti-Bacterial Agents (therapeutic use)
  • Bronchiolitis (drug therapy, immunology)
  • Erythromycin (therapeutic use)
  • Female
  • Histocompatibility Antigens Class I
  • Humans
  • Severe Combined Immunodeficiency (drug therapy)
  • Survivors
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: